• The Magazine
  • Advertising
  • About Us
  • Contact
  • Subscribe
  • Sign in
  • Pharma
  • Medtech
  • Biotech
  • Science
  • Events
  • Careers
  • Jobs
  • Opinion & Debate
  • The Magazine
  • Advertising
  • About Us
  • Contact
Menu
  • Subscribe
  • Sign in

No 01 2026

Malin Otmani

-

February 23, 2026

Share article on X
Share article on Linkedin

Published: February 23, 2026

Top stories

Acquisition – March 10, 2026

ClinStorage acquired by Rubicon Healthcare Partners

ClinStorage has entered a partnership with Rubicon Healthcare Partners, which will become the company’s new majority owner.

In a new job – March 10, 2026

Spago Nanomedical strengthens CMC and supply capabilities

Torsten Malmström has assumed the position of Director CMC & Supply.

Science Award – March 10, 2026

Magnus Essand named Cancer Researcher of the Year

Elicera Therapeutics’ Chief Scientific Officer has been named Cancer Researcher of the Year 2026 by the Swedish Cancer Society (Cancerfonden).

Clinical Trials – March 9, 2026

Oncopeptides secures fast-track designation for Window-of-Opportunity study

Oncopeptides has achieved key regulatory agreement with both the Swedish and Norwegian Medical Products Agencies regarding the design of its planned “Window-of-Opportunity” study evaluating a Peptide Drug Conjugate (PDC) in glioblastoma.

Follow NLS news
Follow us on XFollow us on LinkedinFollow us on Bluesky

Related posts

Acquisition - March 10, 2026

ClinStorage acquired by Rubicon Healthcare Partners

ClinStorage has entered a partnership with Rubicon Healthcare Partners, which will become the company’s new majority owner.

In a new job - March 10, 2026

Spago Nanomedical strengthens CMC and supply capabilities

Torsten Malmström has assumed the position of Director CMC & Supply.

Science Award - March 10, 2026

Magnus Essand named Cancer Researcher of the Year

Elicera Therapeutics' Chief Scientific Officer has been named Cancer Researcher of the Year 2026 by the Swedish Cancer Society (Cancerfonden).

Clinical Trials - March 9, 2026

Oncopeptides secures fast-track designation for Window-of-Opportunity study

Oncopeptides has achieved key regulatory agreement with both the Swedish and Norwegian Medical Products Agencies regarding the design of its planned “Window-of-Opportunity” study evaluating a Peptide Drug Conjugate (PDC) in glioblastoma.

Business article - March 7, 2026

Women’s health: 4 x Nordic efforts

The last two years include a new regional policy charter and dedicated Nordic women's health innovation hub introduced in our region.

Column - March 7, 2026

Women’s health – a new Nordic stronghold

To succeed as a life science cluster in a medium-sized region, you need to prioritize and pick your battles.

Business article - March 7, 2026

The power loop: How female leadership and women’s health reinforce each other

In a region celebrated for gender equality, the life science sector tells a different story: women dominate the workforce in many jobs yet remain sidelined in leadership, funding, and research – with consequences that ripple across public health and economic performance.

Sign up to our Newsletter!

I confirm that I want to subscribe to newsletters from Nordic Life Science and that Nordic Life Science has the right to save my email address. Read our privacy policy here

Read the latest issue!

Sign up for a subscription and read our latest digital issue today.

Sign up
Sign up

The leading life science news channel in the Nordic region.

© NLS Media Group AB – All rights reserved

Digital and print
  • The magazine
  • Subscribe
  • Newsletter
More information
  • About us
  • Contact
  • Advertising
Social media
  • LinkedIn
  • Bluesky
  • X
NLS Media Group AB

St Paulsgatan 13

118 46 Sweden

info@nlsnews.com

+46-8-588 941 51

  • Cookies
  • Data management and privacy policy

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.